Amgen Boasts Success In Sjogren's; Shares Charge Ahead
Unusual Whales
On Tuesday, Amgen's stock showed upward movement above its 50-day line following the release of positive results for its experimental treatment for Sjogren's syndrome. The company's success in this treatment contributed to its stock rising, with shares showing progress. The news highlights Amgen's promising developments in the medical field.
